Loading clinical trials...
Loading clinical trials...
Effects of Intrauterine Administration of Autologous Peripheral Blood Mononuclear Cells (PBMC) on the Endometrial Cells Populations
Conditions
Interventions
Intrauterine administration of autologous peripheral blood mononuclear cells (PBMC)
Locations
2
Bulgaria
Nadezhda Women's Health Hospital
Sofia, Sofia, Bulgaria
Medical diagnostic laboratory Imunovita
Sofia, Bulgaria
Start Date
December 9, 2023
Primary Completion Date
January 3, 2026
Completion Date
December 9, 2026
Last Updated
May 21, 2025
NCT07394530
NCT06921395
NCT06896747
NCT06629636
NCT04866329
NCT07265908
Lead Sponsor
Nadezhda Women's Health Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions